XOMA

Susan Kramer, Dr. P.H., has been named vice president, Project and Alliance Management at XOMA Ltd. Dr. Kramer has 25 years of industry experience at Genentech and two biotechnology companies and a strong focus on product development and alliance management. She will lead and direct the program management activities for XOMA 052, both strategic and operational, from clinical development through approval. She also will provide leadership to the company’s project and alliance management group.

Prior to joining XOMA, Dr. Kramer served as the vice president of development at Anesiva, Inc. where she led the development of Adlea, a non-opioid analgesic. Prior to Anesiva, Susan co-founded Corthera, Inc., and led the development of Relaxin for use in congestive heart failure, orthodontics and preeclampsia. During her 18 years at Genentech, Dr. Kramer served in a number of management positions including senior director of bioanalytical technology, where she supervised a group of more than 100 scientists. She was the project champion and manager of a number of key Genentech projects with partners like Boehringer Ingelheim, Toray Industries, Daiichi Seiyaku and Fujisawa Pharmaceuticals.